IPO Premiums
IPO calendar
ICINNOVACAPListed

Innova Captab Limited

Book Built Issue IPO · NSE, BSE

Price band
₹426 - ₹448
Lot size
33 shares
Issue amount
₹570 cr
Total subscription
56.33×
Current price₹1,001.7
Listing price ₹452.1
Watch live price ↗
Opens
21 Dec 2023
Closes
26 Dec 2023
Allotment
27 Dec 2023
Listing
29 Dec 2023

Offer at a glance

Issue overview

Issue size
1,27,23,214 shares
Face value
₹10 per share
Minimum investment
₹14,058
Fresh issue
₹320 cr
Offer for sale
₹250 cr
Registrar
Kfin Technologies Limited
Listing exchange
NSE, BSE
Maximum investment
₹14,784
Issue type
Book Built Issue IPO
Shares before issue
5,00,82,072
Shares after issue
0

Lot sizes

CategoryLotsSharesAmount
RETAIL133₹14,784
sHNI14462₹2,06,976
bHNI682,244₹10,05,312

Share reservation

Retail35%
NII(HNI)15%
QIB50%

Subscription & GMP

Subscription by category

Total subscribed56.33×

Missing multiples are calculated from bids and offered shares when available.

QIB116.15×
NIB66.83×
HNIs(10L +)73.67×
HNIs (2-10L)53.15×
RETAIL17.64×

GMP history

0163213 Mar: ₹324 Nov: ₹32
13 Mar₹324 Nov

Application-wise demand

CategoryReserved applicationsApplied applications
——

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs11413,240.96
RETAIL199.53,519.75
NIB85.55,713.64
HNIs 2+28.51,514.65
HNIs 10+574,198.99

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profit In Crores
05001,000Mar 2021 · Revenue: 412.03Mar 2021 · Profit after tax: 34.5Mar 2021Mar 2022 · Revenue: 803.41Mar 2022 · Profit after tax: 63.95Mar 2022Mar 2023 · Revenue: 935.58Mar 2023 · Profit after tax: 67.95Mar 2023Jun 2023 · Revenue: 234.37Jun 2023 · Profit after tax: 17.59Jun 2023
RevenueProfit after tax

Key performance indicators

MetricValues
EPS14.16
ROE24.58
ROCE22.61
RONW24.58
PRE IPO(PE)31.64
POST IPO(PE)36.42

Values and labels as reported in the issue data.

Company information

Company profile

Incorporated in January 2005, Innova Captab Limited is a pharmaceutical company operating in three verticals – Contract Development & Manufacturing (CDMO), domestic branded generics, and international branded generics. The company manufactures a wide range of pharmaceutical products including tablets, capsules, dry syrups, injections, ointments and liquid medicines. In FY23 and Q1FY24, the company produced and sold over 600 generic products. Its domestic brands are sold through 5,000+ distributors and ~1.5 lakh retail pharmacies in India. The company also exports branded generics to 20 countries. As of October 31, 2023, Innova Captab employed 29 scientists and engineers, and has its plant in Baddi, Haryana.

Promoters

Manoj Kumar Lohariwala

Vinay Kumar Lohariwala

Registrar & documents

Lead manager

ICICI Securities Limited, Jm Financial Limited

Registered office

601, Proxima, Plot No. 19, Sector 30 A, Vashi, Navi Mumbai, 400 705

+91 22 2564 2095

+91 22 2564 2095Company website ↗

Understanding INNOVACAP IPO data

Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.